glp-1 for weight loss price Study finds 40% of prescriptions go unfilled: Is cost curbing use of drugs? GLP-1 drugs protect against anti-shedding hair treatment Payment Option:Pay in Full | Partners

glp-1 for weight loss price Study finds 40% of prescriptions go unfilled: Is cost curbing use of drugs? GLP-1 drugs protect against anti-shedding hair treatment Payment Option:Pay in Full | Partners

GLP-1 drugs protect against new or worsening addictions, large study shows | Reuters

Zepbound Zepbound and Mounjaro are both brand-name medications containing tirzepatide, a dual GIP/GLP-1 receptor agonist

anti-shedding hair treatment

Payment Option:Pay in Full | Partners

Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes.¹ The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that “parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes.”¹ As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbidities—precisely the populations populating ophthalmic clinics—the field may not have the luxury of waiting for cleaner data